Characteristics of Hepatitis C Epidemic Process in the Republic of Belarus

QR Code

Characteristics of Hepatitis C Epidemic Process in the Republic of Belarus

Relevance. The medical and social significance of hepatitis C (HC) is determined by its widespread distribution, the involvement of the working-age population in the epidemic process, the multiplicity of transmission routes of the pathogen, a variety of clinical forms, and a high frequency of chroni...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. S. Vysotskaya, N. D. Kolomiets, E. L. Gasich, O. N. Hanenko, O. V. Tonko, I. N. Glinskaya, O. N. Romanova, A. N. Kabankova
Format:	Article
Language:	Russian
Published:	Numikom LLC 2021-01-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	hepatitis c virus epidemic process hepatitis c virus genotypes chronic hepatitis c acute hepatitis c incidence risk groups
Online Access:	https://www.epidemvac.ru/jour/article/view/1135
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genotypic Diversity of Hepatitis C Virus in Tuberculosis Patients in the Tomsk Region
by: K. A. Svirin, et al.
Published: (2025-03-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Chronic Hepatitis С in Siberian Federal District: Analysis of a Case Rate and Evolution of Genotypes of the Originator
by: E. D. Savilov, et al.
Published: (2018-09-01)

Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)

The incidence of chronic viral hepatitis and the analysis of the genetic diversity of hepatitis B and C viruses among the population of Khabarovsk city
by: Valeriya O. Kotova, et al.
Published: (2025-03-01)

Clinical and Epidemiological Characteristics of Hepatocellular Carcinoma in the Republic of Saha (Yakutia)
by: S. S. Sleptsova, et al.
Published: (2020-07-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

Infección por hepatitis C: Enfoque para dermatólogos
by: Ximena Hormaza
Published: (2003-06-01)

Results of the Campaign Dedicated to World Hepatitis Day
by: V. V. Klushkina, et al.
Published: (2025-07-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

Reconstruction of recombination sites in genomic structures of the strains of genotype 6 of hepatitis C virus
by: N. E. Garashchenko, et al.
Published: (2016-09-01)

Variety of genotypes of a HCV virus and outcomes of chronic hepatitis C: results 5 summer supervision in the territory of the Kirov region
by: S. V. Baramzina, et al.
Published: (2014-09-01)

DETECTION OF HEPATITIS C VIRUS-SPECIFIC REPLICATION MARKERS IN PERIPHERAL BLOOD MONONUCLEARS FROM THE PATIENTS WITH CHRONIC HEPATITIS C
by: T. V. Vishnevskaya, et al.
Published: (2014-07-01)

Cytokine profiling of plasma in patients with viral hepatitis C
by: N. A. Arsentieva, et al.
Published: (2024-11-01)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
by: S. V. Zhavoronok, et al.
Published: (2018-10-01)

Betaleukin in therapy of chronic hepatitis C
by: E. S. Romanova, et al.
Published: (2014-10-01)

Kinetics of Virus Load HCV-RNA in Blood Serum and Peripheral Mononuclear Cells in a Patient with Hepatocirrhosis and Chronic Virus Hepatitis C Termination Treated According to Noninterferon Treatment Scheme (Cycloferon + Ribavirin)
by: V. C. Stelmah, et al.
Published: (2020-05-01)

Diffuse large B-cells lymphoma clinical features in patients with hepatitis B and C infection
by: G. I. Storozhakov, et al.
Published: (2022-11-01)

CYTOKINES, CHEMOKINES AND GROWTH FACTORS ASSOCIATED WITH CHRONIC VIRAL HEPATITIS C
by: Natalia A. Arsentieva, et al.
Published: (2019-08-01)

HCV Infection in the Republic of Sakha (Yakutia) and Its Role of Genotypes in Clinical Outcomes of the Disease
by: V. K. Semenova, et al.
Published: (2020-09-01)

Immunocompromentation of persons from groups with high risk of parenteral contamination with hepatitis B and C viruses: mechanisms of development and clinical pathogenetical significance
by: M. K. Mamedov, et al.
Published: (2014-09-01)

Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C
by: A. I. Gubenko, et al.
Published: (2023-12-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021
by: Olena Nesterova
Published: (2025-07-01)

TNFα PRODUCTION AND APOPTOSIS REGULATION IN VIRAL HEPATITIS TYPE C
by: V. V. Novitsky, et al.
Published: (2014-07-01)

THE RELATIONSHIP BETWEEN DURATION OF DIALYSIS AND HISTORY OF BLOOD TRANSFUSION WITH HEPATITIS C SEROPREVALENCE IN HEMODIALYSIS PATIENTS: A CROSS-SECTIONAL STUDY AT GADJAH MADA UNIVERSITY ACADEMIC HOSPITAL
by: Kurnia Fitriasari, et al.
Published: (2025-07-01)

VIRAL HEPATITIS B AND C AS COMORBIDITY IN RHEUMATIC DISEASES: ANALYSIS OF THE DATA OF THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY CLINIC OVER 4 YEARS
by: A. E. Karateev, et al.
Published: (2016-07-01)

Factors Associated with Hepatitis B and Hepatitis C among Infected Patients in Indonesia and Their Knowledge and Attitude: A Multicenter Observational Study
by: Juferdy Kurniawan, et al.
Published: (2024-07-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

SOLUBLE FORMS OF MEMBRANOUS ANTIGENS IN SERUM OF PATIENTS WITH HEPATITIS C
by: T. V. Vishnevskaya, et al.
Published: (2014-07-01)

Broadly Neutralizing Antibody Characteristics in Hepatitis C Virus Infection and Implications for Vaccine Design
by: Nicole E. Skinner
Published: (2025-06-01)

Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01)

Clinical and epidemiological characteristics of D hepatitis В and delta in the Republic of Dagestan
by: S. A. Magomedova, et al.
Published: (2023-10-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Evaluation Transplantation of Bone-Derived Mesenchymal Stem Cell in the Patients with Hepatitis C-Related Liver Cirrhosis (Pi lot Study)
by: S. P. Lukashyk, et al.
Published: (2021-03-01)

Hepatitis C: una aproximación clínica y epidemiológica en Cali, Colombia
by: Carlos Arturo Rojas Rodríguez, et al.
Published: (2018-12-01)

Chaos in the diagnosis of hepatitis C virus in hemodialysis patients
by: Ananthapadmanabasamy Indira, et al.
Published: (2024-12-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)